Rankings
▼
Calendar
HOWL Q4 2020 Earnings — Werewolf Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HOWL
Werewolf Therapeutics, Inc.
$41M
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$7M
Net Income
-$7M
EPS (Diluted)
$0.00
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$221,000
Balance Sheet
Total Assets
$96M
Total Liabilities
$148M
Stockholders' Equity
-$52M
Cash & Equivalents
$93M
← FY 2020
All Quarters
Q1 2021 →
